TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Bio Vitos Pharma AB
Closing information (x1000 NOK)
Closing information | 2023/12 (consolidated) | 2022/12 | 2021/12 |
Turnover |
3,035
|
1,249
|
1,093 |
Financial expenses |
0
![]() |
0
|
1 |
Earnings before taxes |
-13,035
|
-14,094
|
-13,608 |
EBITDA |
-3,550
|
-7,354
|
-7,347 |
Total assets |
34,361
|
25,019
|
34,617 |
Current assets |
5,179
|
4,940
|
10,824 |
Current liabilities |
1,021
|
1,444
|
1,913 |
Equity capital |
33,340
|
23,575
|
32,704 |
- share capital |
4,334
|
2,926
|
1,693 |
Employees (average) |
1
|
5
|
6 |
Financial ratios
Fiscal year | 2023/12 (consolidated) | 2022/12 | 2021/12 |
Solvency |
97.0%
|
94.2%
|
94.5% |
Turnover per employee |
3,035
|
250
|
182 |
Profit as a percentage of turnover |
-429.5%
|
-1128.4%
|
-1245.0% |
Return on assets (ROA) |
-37.9%
|
-56.3%
|
-39.3% |
Current ratio |
507.2%
|
342.1%
|
565.8% |
Return on equity (ROE) |
-39.1%
|
-59.8%
|
-41.6% |
Change turnover | |||
Change turnover % |
18%
|
265% | |
Chg. No. of employees | |||
Chg. No. of employees % |
-17%
|
20% |
Total value of public sale
Fiscal year | 2023/12 (consolidated) | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.